№ lp_1_2_24201
File format: docx Character count: 7123 File size: 34 KB
Professionally framed justification letter outlining clinical rationale, regulatory indication, efficacy data, safety profile, and literature references supporting payer coverage of a specific ophthalmic medication.
Document type: Medical necessity letter
Therapeutic area: Ophthalmology
Indication: Reduction of intraocular pressure in open-angle glaucoma or ocular hypertension
Medication name: VYZULTA (latanoprostene bunod ophthalmic solution)
Dosage strength: 0.024%
Drug class: Prostaglandin analogue with nitric oxide–donating activity
Regulatory status: FDA-approved prescription medication
Manufacturer: Bausch & Lomb Inc.
Intended recipient: Health insurance payer or medical director
Target population: Patients with open-angle glaucoma or ocular hypertension
Clinical evidence referenced: Phase 2 VOYAGER study; Phase 3 APOLLO and LUNAR studies; real-world retrospective studies
Safety information included: Yes
References: Peer-reviewed journals and prescribing information
Source type: Industry-provided informational material
Price: 8 / 10 USD
The file will be delivered to the email address provided at checkout within 12 hours.

Don’t have cryptocurrency yet?

You can still complete your purchase in a few minutes:
  1. Buy Crypto in a trusted app (Coinbase, Kraken, Cash App or any similar service).
  2. In the app, tap Send.
  3. Select network, paste our wallet address.
  4. Send the exact amount shown above.
After sending, paste your TXID (transaction ID) and your email to receive the download link. Need help? Contact support and we’ll guide you step by step.

The final amount may vary slightly depending on the payment method.
The file will be sent to the email address provided at checkout within 24 hours.
The product description is provided for reference. Actual content and formatting may differ slightly.